Kidney Transplantation With Sirolimus and Mycophenolate Mofetil–Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to Calcineurin Inhibitor Drugs-Reference-Cited by-同舟云学术

Kidney Transplantation With Sirolimus and Mycophenolate Mofetil–Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to Calcineurin Inhibitor Drugs

Published:2007-04-15 Issue:7 Volume:83 Page:883-892
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Flechner Stuart M.,Goldfarb David,Solez Kim,Modlin Charles S.,Mastroianni Barbara,Savas Kathy,Babineau Denise,Kurian Sunil,Salomon Daniel,Novick Andrew C.,Cook Daniel J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference46 articles.

1. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.;Meier-Kriesche;Am J Transplantation,2004

2. Chronic allograft nephropathy.;Colvin;NEJM,2003

3. The natural history of chronic allograft nephropathy.;Nankivell;NEJM,2003

4. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology.;Nankivell;Transplantation,2004

5. Post transplant renal function in the first year predicts long-term kidney transplant survival.;Hariharan;Kidney Int,2002

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Tacrolimus Formulation on Cerebral Blood Flow and Cognitive Function;Transplantation Direct;2023-07-12

2. The immune profiles and “minimizing tacrolimus” strategy for long-term survival recipients after liver transplantation;Hepatobiliary & Pancreatic Diseases International;2021-04

3. Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review;World Journal of Transplantation;2021-03-18

4. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16

5. Development of a biomarker of efficacy in second-line treatment for lymphangioma of the tongue: a pilot study;British Journal of Oral and Maxillofacial Surgery;2019-12